{
    "Trade/Device Name(s)": [
        "ReliOn Ultima Advance Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K081975",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051213"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "October 24, 2008",
    "Summary Letter Received Date": "October 27, 2008",
    "Submission Date": "October 16, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Single Analyte Control Solution"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ReliOn Ultima Advance Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Meter",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for ReliOn Ultima Advance Blood Glucose Monitoring System for quantitative measurement of glucose in whole blood using amperometric biosensor technology",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh whole blood for self-testing by lay users or professional use in management of diabetes; not intended for neonatal samples",
    "fda_folder": "Clinical Chemistry"
}